Chromatin immunoprecipitation (ChIP) is an indispensable tool in the fields of epigenetics and gene regulation that isolates specific protein-DNA interactions. ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin. However, ChIP-seq is hampered by relatively low mapping resolution of several hundred base pairs and high background signal. The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise. The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site. The ChIP-exo libraries are then subjected to high throughput sequencing. The resulting data can be leveraged to provide unique and ultra-high resolution insights into the functional organization of the genome. Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform.
Introduction
Chromatin immunoprecipitation (ChIP) is a powerful method to study mechanisms of gene regulation by selectively enriching for DNA fragments that interact with a given protein in living cells. Detection methods of ChIP-enriched DNA fragments have evolved as technology improves, from detection of a single locus (standard ChIP-qPCR) to hybridization on oligonucleotide microarrays (ChIP-chip) to high-throughput sequencing (ChIP-seq)
Figure 3: ChIP-exo Spatially Resolves Distinct Bidirectional Transcription Initiation Complexes. (A)
Smoothed distribution of strandseparated ChIP-exo tag 5' ends for Pol II, TFIIB, and TBP at the human RPS12 gene in proliferating K562 cells. (B) Averaged ChIP-exo patterns around the closest RefSeq TSS. Peak-pair tags were aligned to the TSS gene-by-gene, binned in non-overlapping 10bp intervals relative to the TSS, and then the average peak-pair density value across all TFIIB-occupied (n = 6,511) genes was plotted as a percent of the total. The "spikes" of TBP and TFIIB are indiscernible (vertically offset in inset). (C) Model based on panel B data, illustrating distinct transcription initiation complexes resolved by ChIP-exo (black trace). Pol II occupied two separate resolvable locations that coincided with sites of divergent transcription initiation ("Divergent") and "Pause" sites. This clear spatial separation of Pol II complexes indicates that divergent transcripts arise from distinct initiation complexes. The vast majority Pol II crosslinked about 50 bp downstream of the TSS at the "Pause" site, where it is expected to pause after initiating transcription. Pol II was most depleted 20 -60 bp upstream of the TSS where the pre-initiation complex ("PIC") forms, indicating that on average it likely spends less time there than at the paused sites. This suggests that in most (but not necessarily all) cases, once Pol II is recruited, it rapidly clears the promoter and assumes a paused-state approximately 30 -50 bp downstream of the TSS, consistent with the observation that Pol II pause release is a rate-limiting step in transcription. These adjacent initiation complexes are unresolvable by ChIP-seq (illustrated by gray fill trace) since its resolution is limited to a few hundred base pairs. Figure 
Discussion
We present a functional genomic protocol to determine the precise binding location for chromatin interacting proteins in an unbiased, genomewide manner at near base pair resolution. The most critical step to achieve near base pair mapping resolution is the exonuclease treatment of the ChIP-enriched DNA while the immunoprecipitate remains on the magnetic resin. Ostensibly, protein complexes could potentially block in vivo footprinting of any given subunit (e.g., chromatin remodeling complexes or the nucleosome core particle). However, as reported previously 10 , since formaldehyde is an inefficient crosslinker, it becomes increasingly unlikely that multiple subunits of a complex would crosslink to DNA and each other in the same cell at the same locus. Thus, in vivo footprinting of individual subunits of a protein complex, such as individual histone subunits of a nucleosome, is possible with ChIP-exo.
The most notable advantages of ChIP-exo are its near base pair resolution and low background. The ultra-high resolution permits detailed structural and spatial insights to be made on a genome-wide scale that are not currently possible with any other method. On the other hand, the primary limitation of ChIP-exo is that it is a technically challenging molecular biology methodology to master. In addition, the general limitations of the ChIP step also apply to ChIP-exo (e.g., commercial antibody availability and specificity, epitope accessibility, and relatively large number of cells required). Common pitfalls include poor quality sonicated extracts, using a non-ChIP grade antibody, and not keeping samples on ice as much as possible. Thus, sonication conditions must be carefully optimized and each antibody validated as previously described 18 to avoid the detrimental effects these parameters can have on the experimental outcome.
As far as sequencing depth for a transcription factor target, we typically aim for about 20 million uniquely aligned reads. Since Pol II and histone modifications are more broadly distributed, we aim for 30 to 50 million reads. It is important to note that since ChIP-exo has substantially less background than ChIP-seq, fewer reads are required to achieve similar sequencing depth.
The ChIP-exo technology is now being widely adopted despite its technical challenges, as robust variations on the original protocol continue to be published 17, 19, 20 . In particular, one variation that may prove useful for difficult to ChIP proteins is called ChIP-nexus, which uses a single ligation step to increase the efficiently of the library preparation 20 . In summary, ChIP-exo is an increasingly employed and powerful methodology for ultra-high resolution mapping of chromatin interacting proteins on a global scale. As the list of commercially available ChIPgrade antibodies continues to grow, future applications of the ChIP-exo methodology will be directed at mapping uncharted gene regulatory networks to understand the molecular circuitry of the cell in ultra-high resolution. In addition, ChIP-exo will likely be further refined and adapted to footprint in vivo protein-RNA interactions at near base pair resolution.
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